A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options. Issue 12 (18th September 2015)

Record Type:: Journal Article
Title:: A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options. Issue 12 (18th September 2015)
Main Title:: A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options
Authors:: Eisner, Florian
Pichler, Martin
Goletz, Steffen
Stoeger, Herbert
Samonigg, Hellmut
Abstract:
Is Part Of:: Journal of clinical pathology. Volume 68:Issue 12(2015)
Journal:: Journal of clinical pathology
Issue:: Volume 68:Issue 12(2015)
Issue Display:: Volume 68, Issue 12 (2015)
Year:: 2015
Volume:: 68
Issue:: 12
Issue Sort Value:: 2015-0068-0012-0000
Page Start:: 1044
Page End:: 1046
Publication Date:: 2015-09-18
Subjects:: COLORECTAL CANCER -- MONOCLONAL ANTIBODY -- CANCER
Pathology -- Periodicals
Pathology, Molecular -- Periodicals
616.0705
Journal URLs:: http://jcp.bmjjournals.com ↗
http://jcp.bmjjournals.com/content/by/year ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=162&action=archive ↗
http://www.bmj.com/archive ↗
DOI:: 10.1136/jclinpath-2015-202996 ↗
Languages:: English
ISSNs:: 0021-9746
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 18056.xml